“…By quantification of the resultant oxTMB concentration, which correlates with the absorbance signal, the analytes can be determined. So far, these sensing platforms have been widely used for the detection of AA, alkaline phosphatase (ALP), and acid phosphatase (ACP) . Despite the development of numerous OXD-based “signal-off” sensing platforms, there remains a critical need to enhance their performance in terms of lowering the limit of detection (LOD) and expanding the linear range (LR) to improve their clinical utility.…”